Skin disease trial shows 62% response at 40 weeks, no new safety signals Up to 32% reached HiSCR100 and 25% achieved inflammatory remission in Phase 3 HS trials. MoonLake expects 52-week data in Q2 2026.

#MLTX MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

www.stocktitan.net/news/MLTX/moon-lake-anno...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MOS, #LAW, #MLTX, #PEPG, #MT

#OptionFlow #OptionsTrading #Trading

JUST IN: ( NASDAQ: #MLTX ) Buy Recommendation Issued On MLTX By BTIG

Most Searched, Thursday January 8, 2026 – Crystal Equity Research

Most searched small-cap stocks, Thu Jan 8th - #MLTX #RZLV #SHCO #RR #VTYX #ELME #ACRV #ACON #SERV #DNN #NEOG #TE #FLYX #TLRY #SG #RDW #IDR #HYMC #CRML #AEVA - More: crystalequityresearch.com/most-searche... #smallcap

MoonLake Immunotherapeutics Under Fire for Securities Law Breaches - What Investors Should Know A class action lawsuit has been initiated against MoonLake Immunotherapeutics for alleged violations of securities laws. Learn about the details of the case and your rights as an investor.

MoonLake Immunotherapeutics Under Fire for Securities Law Breaches - What Investors Should Know #USA #Los_Angeles #DJS_Law_Group #MLTX #MoonLake_Immunotherapeutics

Investors Urged to Act on MoonLake Immunotherapeutics Class Action Lawsuit Before 2025 Deadline MoonLake Immunotherapeutics is facing a class action lawsuit. Investors are encouraged to take action before the December 2025 deadline for claims and restitution.

Investors Urged to Act on MoonLake Immunotherapeutics Class Action Lawsuit Before 2025 Deadline #USA #New_York #Class_Action #MLTX #MoonLake_Immunotherapeutics

MoonLake Immunotherapeutics Shareholders Alert: Important Class Action Announcement MoonLake Immunotherapeutics investors are urged to take action regarding a class action lawsuit with a lead plaintiff deadline approaching on December 15, 2025. Seek important details.

MoonLake Immunotherapeutics Shareholders Alert: Important Class Action Announcement #United_States #New_York #Gross_Law_Firm #MoonLake #MLTX

Investors Target MoonLake Immunotherapeutics in Class Action Securities Lawsuit MoonLake Immunotherapeutics faces a class action lawsuit for alleged violations of securities laws. Investors are encouraged to participate for recovery.

Investors Target MoonLake Immunotherapeutics in Class Action Securities Lawsuit #DJS_Law_Group #MLTX #MoonLake_Immunotherapeutics

MoonLake Immunotherapeutics Investors Have Chance to Join Securities Fraud Lawsuit Investors of MoonLake Immunotherapeutics (MLTX) who have incurred losses can now join a securities fraud class action lawsuit. Time is of the essence.

MoonLake Immunotherapeutics Investors Have Chance to Join Securities Fraud Lawsuit #USA #Class_Action #Los_Angeles #MoonLake #MLTX

Legal Action Alert: MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations MoonLake Immunotherapeutics is facing a class action lawsuit for allegedly misrepresenting its drug's efficacy compared to competitors. Shareholders may be eligible for recovery.

Legal Action Alert: MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations #United_States #DJS_Law_Group #Eastchester #MoonLake #MLTX

Class Action Lawsuit Against MoonLake Immunotherapeutics Triggers Recovery Efforts for Investors A class action lawsuit filed against MoonLake Immunotherapeutics seeks to recover losses for investors affected by alleged securities fraud.

Class Action Lawsuit Against MoonLake Immunotherapeutics Triggers Recovery Efforts for Investors #United_States #New_York #Levi_Korsinsky #MLTX #MoonLake_Immunotherapeutics

Gross Law Firm Alerts MoonLake Investors About Key Class Action Deadline for December 2025 The Gross Law Firm reminds shareholders of MoonLake Immunotherapeutics about a lead plaintiff deadline on December 15, 2025, urging class members to take action.

Gross Law Firm Alerts MoonLake Investors About Key Class Action Deadline for December 2025 #United_States #New_York #Gross_Law_Firm #MLTX #MoonLake_Immunotherapeutics

Investors File Class Action Against MoonLake Immunotherapeutics Over Securities Violations A class action lawsuit has been initiated against MoonLake Immunotherapeutics for securities law violations. Shareholders are urged to take action before the deadline.

Investors File Class Action Against MoonLake Immunotherapeutics Over Securities Violations #USA #New_York #DJS_Law_Group #MLTX #MoonLake_Immunotherapeutics

MoonLake's Efficacy Claims Face Legal Challenges Amid 90% Stock Drop Recent claims from Hagens Berman reveal troubling gaps in MoonLake's SLK efficacy, plunging stock values, and potential legal actions for investors affected by these issues.

MoonLake's Efficacy Claims Face Legal Challenges Amid 90% Stock Drop #USA #San_Francisco #Hagens_Berman #MoonLake #MLTX

MoonLake Immunotherapeutics Shareholders Have Chance to Lead Class Action Lawsuit for Securities Fraud MoonLake Immunotherapeutics investors who experienced significant losses can now take the opportunity to lead a class action lawsuit against the company for alleged securities fraud.

MoonLake Immunotherapeutics Shareholders Have Chance to Lead Class Action Lawsuit for Securities Fraud #None #Securities_Fraud #Bensalem #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations MoonLake Immunotherapeutics is facing a class action lawsuit for alleged violations of securities laws. Affected investors can act before the deadline.

MoonLake Immunotherapeutics Faces Class Action Lawsuit for Securities Violations #United_States #New_York #Levi_Korsinsky #MoonLake #MLTX

MoonLake Immunotherapeutics Shareholders Have Chance to Join Securities Class Action Suit Shareholders of MoonLake Immunotherapeutics who have incurred losses may now have the opportunity to lead a class action lawsuit related to securities fraud. Mark your calendars for the deadline.

MoonLake Immunotherapeutics Shareholders Have Chance to Join Securities Class Action Suit #USA #Los_Angeles #Securities_Fraud #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Class Action Lawsuit Over Securities Violations Investors are reminded of a class action lawsuit against MoonLake Immunotherapeutics for securities law violations. Possible lead plaintiff appointments are available.

MoonLake Immunotherapeutics Faces Class Action Lawsuit Over Securities Violations #Securities_Law #MLTX #MoonLake_Immunotherapeutics

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX {"summary":"","positive":[],"negative":[],"faq":[]}

#MLTX MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX

www.stocktitan.net/news/MLTX/moon-lake-immu...

Faruqi & Faruqi Alerts MoonLake Investors About Class Action Deadline on December 15, 2025 Faruqi & Faruqi, LLP reminds investors in MoonLake of the upcoming deadline for lead plaintiff status in a securities class action lawsuit set for December 15, 2025.

Faruqi & Faruqi Alerts MoonLake Investors About Class Action Deadline on December 15, 2025 #USA #New_York #Faruqi_&_Faruqi #MoonLake #MLTX

Investors to Join MoonLake Immunotherapeutics Class Action for Alleged Securities Fraud by December 2025 A class action lawsuit has been initiated against MoonLake Immunotherapeutics over alleged securities fraud. Investors can join before December 2025.

Investors to Join MoonLake Immunotherapeutics Class Action for Alleged Securities Fraud by December 2025 #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Lawsuit for Misleading Securities Practices Affecting Shareholders' Rights MoonLake Immunotherapeutics has come under fire with a lawsuit alleging securities law violations. Shareholders should act promptly to protect their rights.

MoonLake Immunotherapeutics Faces Lawsuit for Misleading Securities Practices Affecting Shareholders' Rights #USA #New_York #Securities_Law #MoonLake #MLTX

Opportunity for MoonLake Immunotherapeutics Investors to Lead a Class Action Lawsuit Investors who has faced losses with MoonLake Immunotherapeutics can take action. The Law Offices of Frank R. Cruz invites participation in a potential fraud lawsuit against the company.

Opportunity for MoonLake Immunotherapeutics Investors to Lead a Class Action Lawsuit #USA #Los_Angeles #Securities_Fraud #MLTX #MoonLake_Immunotherapeutics

MoonLake Immunotherapeutics Faces Class Action Over Securities Violations: What Investors Need to Know Next Investors in MoonLake Immunotherapeutics are alerted to a class action lawsuit concerning securities fraud. Details and contact information provided.

MoonLake Immunotherapeutics Faces Class Action Over Securities Violations: What Investors Need to Know Next #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Securities Law Breaches Investors are urged to join a class action lawsuit against MoonLake Immunotherapeutics for alleged breaches of securities laws. Discover your rights and join the fight.

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Securities Law Breaches #United_States #Los_Angeles #Lawsuit #MoonLake #MLTX

Investors of MoonLake Immunotherapeutics Encouraged to Join Class Action Lawsuit Investors who suffered losses from MoonLake Immunotherapeutics securities are urged to join a class action lawsuit led by Schall Law Firm before the December deadline.

Investors of MoonLake Immunotherapeutics Encouraged to Join Class Action Lawsuit #USA #Los_Angeles #Schall_Law_Firm #MoonLake #MLTX

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX {"summary":"","positive":[],"negative":[],"faq":[]}

#MLTX MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX

www.stocktitan.net/news/MLTX/moon-lake-immu...

Class Action Lawsuit Notifies MoonLake Immunotherapeutics Investors: Important Details Inside MoonLake Immunotherapeutics is facing a class action lawsuit over alleged misleading statements. Investors must register by December 15, 2025.

Class Action Lawsuit Notifies MoonLake Immunotherapeutics Investors: Important Details Inside #USA #New_York #Gross_Law_Firm #MLTX #MoonLake_Immunotherapeutics

MoonLake Immunotherapeutics Shareholders Face Class Action Fraud Opportunity Investors in MoonLake Immunotherapeutics who suffered losses can lead a class action lawsuit for alleged securities fraud. Key details inside.

MoonLake Immunotherapeutics Shareholders Face Class Action Fraud Opportunity #USA #Securities_Fraud #Bensalem #MoonLake #MLTX

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Alleged Securities Fraud Investors in MoonLake Immunotherapeutics may be entitled to compensation due to a class action lawsuit alleging securities fraud. Act before the December deadline.

Class Action Lawsuit Filed Against MoonLake Immunotherapeutics for Alleged Securities Fraud #USA #New_York #Levi_&_Korsinsky #MoonLake #MLTX